Hypofractionated whole breast radiotherapy : Impact on depatmental waiting times and cost

Dwyer, P., Hickey, B., Burmwister, E. and Burmeister, B. (2010) Hypofractionated whole breast radiotherapy : Impact on depatmental waiting times and cost. Journal of Medical Imaging and Radiation Oncology, 54 3: 229-234. doi:10.1111/j.1754-9485.2010.02163.x


Author Dwyer, P.
Hickey, B.
Burmwister, E.
Burmeister, B.
Title Hypofractionated whole breast radiotherapy : Impact on depatmental waiting times and cost
Journal name Journal of Medical Imaging and Radiation Oncology   Check publisher's open access policy
ISSN 1754-9477
1754-9485
Publication date 2010
Sub-type Article (original research)
DOI 10.1111/j.1754-9485.2010.02163.x
Volume 54
Issue 3
Start page 229
End page 234
Total pages 6
Place of publication Richmond, VIC, Australia
Publisher Wiley-Blackwell Publishing Asia
Language eng
Formatted abstract
Conventionally fractionated breast radiation therapy is delivered over 5-6 weeks. Randomised evidence has shown that hypofractionated whole-breast radiotherapy (HWBRT) over 3 weeks results in similar local control without increased toxicity. HWBRT is not standard practice in Australia for all eligible women. We examined the effect of using HWBRT (for eligible patients) on waiting lists and monetary costs. We identified factors associated with prescribing HWBRT. The Princess Alexandra Hospital Radiation Oncology Database was searched for all women with breast cancer treated with adjuvant radiotherapy in 2008. Included patients had undergone breast conserving surgery and had T1-2N0 tumours with negative margins. Women with large breasts and those receiving nodal irradiation were excluded. The outcome evaluated was fractionation schedule. Patient, tumour and treatment factors associated with the use of HWBRT were examined. The impact on departmental resources and health-care costs were calculated assuming the entire cohort received HWBRT. Two hundred seventy-nine patients met the inclusion criteria. Sixty-seven (24%) of these patients were treated with HWBRT. Compared with the conventionally fractionated breast radiation therapy group, the HWBRT group were older (median 69 vs. 54 years; P < 0.001) and more likely to have smaller tumours (12 mm vs. 15 mm; P = 0.02). Had all eligible patients received HWBRT an extra 14 patients each month could be treated and health-care costs would be reduced by 24%. HWBRT was more frequently prescribed in older women with small tumours. More widespread use of HWBRT would allow significantly more patients to be treated each month with considerable cost savings.
Keyword Breast neoplasms
Dose Fractionation
Health-care Costs
Radiotherapy
Waiting lists
Q-Index Code C1
Q-Index Status Provisional Code
Institutional Status Unknown

Document type: Journal Article
Sub-type: Article (original research)
Collections: ERA 2012 Admin Only
School of Medicine Publications
 
Versions
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 19 times in Thomson Reuters Web of Science Article | Citations
Scopus Citation Count Cited 25 times in Scopus Article | Citations
Google Scholar Search Google Scholar
Created: Fri, 25 Nov 2011, 15:53:27 EST by Patrick Dwyer on behalf of Medicine - Princess Alexandra Hospital